Comparing clot-busting medicine versus catheter treatment for serious lung blood clot
Part of Blood & lymphatic, Heart & circulation, Lungs & breathing clinical trials.
This study compares two ways to treat a serious pulmonary embolism (a blood clot in the lungs): using clot-busting medicine delivered through an IV, or using a catheter (a thin tube) to guide treatment directly to the clot. The goal is to find which approach works better and is safer for people at intermediate-high risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a pulmonary embolism (a blood clot in the lungs) that is considered 'intermediate-high risk' — meaning it is serious but not immediately life-threatening.
- You are 18 years old or older.
- You do not have masses (abnormal growths) in your heart that could complicate treatment.
- You are willing to accept either treatment approach being tested.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests three ways of using a catheter (a thin tube) to remove or break up blood clots in the lungs for people with a serious but stable type of pulmonary embolism. The goal is to find the best approach to improve recovery and reduce complications.
This trial tests a procedure to remove blood clots from the lungs using a tube (catheter) to open blocked vessels. It may help people with a sudden pulmonary embolism who are stable enough to undergo the procedure.
This trial tests two ways to treat a serious blood clot in the lungs: removing the clot with a small tube (catheter) alone, or combining that with a low dose of clot-dissolving medicine. The goal is to find a safer and effective treatment for people who can't have standard clot-busting treatment.
This study looks at how well different treatments work for a blood clot in the lung (pulmonary embolism). It includes people who are getting or have already gotten a clot-dissolving medicine or a catheter procedure to remove the clot.
This study compares different real-world treatments for a serious but stable type of blood clot in the lungs (called intermediate-high risk pulmonary embolism). It aims to see which treatments work best in everyday patients, including those with other health conditions.
This study looks at how well a catheter (a thin tube) works to treat a serious type of blood clot in the lungs. It is for people who have a large clot that is causing problems like fast heart rate or low blood pressure.
Hear when a new Acute Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.